1. Home
  2. List
Reference Patent

Reference - List

  • 318 Hits
  • Search Condition : Filter (MeSH = Antineoplastic Agents / pharmacology)
Species Resource Title
Human and Animal Cells K562(RCB0027) Asciminib, a novel allosteric inhibitor of BCR-ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance.
Human and Animal Cells HuCCT1(RCB1960) BEX2 is required for maintaining dormant cancer stem cell in hepatocellular carcinoma.
Human and Animal Cells HL60(RCB0041) Additive antitumor effect of arsenic trioxide with exposure to ionizing radiation to human acute promyelocytic leukemia HL‑60 cells.
Human and Animal Cells Hep G2(RCB0549) Preparations of vitamin D analogs, spirostanols and furostanols from diosgenin and their cytotoxic activities.
Human and Animal Cells Meth-A(RCB0464) Requirement of the acquired immune system in successful cancer chemotherapy with cis-diamminedichloroplatinum (II) in a syngeneic mouse tumor transplantation model.
Human and Animal Cells Jurkat(RCB0806) , 293(RCB1637) A novel type IIb L-asparaginase from Latilactobacillus sakei LK-145: characterization and application.
Human and Animal Cells B16 melanoma 4A5(RCB0557) Medicinal flowers. XXXVI.1) Acylated oleanane-type triterpene saponins with inhibitory effects on melanogenesis from the flower buds of Chinese Camellia japonica.
Human and Animal Cells A549(RCB0098) Cytotoxic activity of quassinoids from Eurycoma longifolia.
Human and Animal Cells TE-1(RCB1894) , TE-4(RCB2097) , TE-5(RCB1949) , TE-6(RCB1950) , TE-8(RCB2098) , TE-9(RCB1988) , TE-10(RCB2099) , TE-11(RCB2100) , TE-14(RCB2101) , TE-15(RCb1951) Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma.
Human and Animal Cells B16 melanoma 4A5(RCB0557) Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.
Human and Animal Cells Saos-2(RCB0428) Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells.
Human and Animal Cells KP4(RCB1005) LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models.
Human and Animal Cells HHUA(RCB0658) Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
Human and Animal Cells MCF7(RCB1904) Suppression of heregulin β signaling by the single N-glycan deletion mutant of soluble ErbB3 protein.
Human and Animal Cells MDA-MB-453(RCB1192) Chemotherapy with hybrid liposomes for human breast tumors along with apoptosis in vivo.
Human and Animal Cells HL60(RCB0041) Importance of inducible multidrug resistance 1 expression in HL-60 cells resistant to gemtuzumab ozogamicin.
Human and Animal Cells HKBMM(RCB0680) Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma.
Human and Animal Cells OCUB-M(RCB0881) Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes.
Human and Animal Cells OS-RC-2(RCB0735) Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer.
Human and Animal Cells HGC-27(RCB0500) Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells.